Literature DB >> 22402012

Adaptation of aminoacylation identity rules to mammalian mitochondria.

Aurélie Fender1, Agnès Gaudry, Frank Jühling, Marie Sissler, Catherine Florentz.   

Abstract

Many mammalian mitochondrial aminoacyl-tRNA synthetases are of bacterial-type and share structural domains with homologous bacterial enzymes of the same specificity. Despite this high similarity, synthetases from bacteria are known for their inability to aminoacylate mitochondrial tRNAs, while mitochondrial enzymes do aminoacylate bacterial tRNAs. Here, the reasons for non-aminoacylation by a bacterial enzyme of a mitochondrial tRNA have been explored. A mutagenic analysis performed on in vitro transcribed human mitochondrial tRNA(Asp) variants tested for their ability to become aspartylated by Escherichia coli aspartyl-tRNA synthetase, reveals that full conversion cannot be achieved on the basis of the currently established tRNA/synthetase recognition rules. Integration of the full set of aspartylation identity elements and stabilization of the structural tRNA scaffold by restoration of D- and T-loop interactions, enable only a partial gain in aspartylation efficiency. The sequence context and high structural instability of the mitochondrial tRNA are additional features hindering optimal adaptation of the tRNA to the bacterial enzyme. Our data support the hypothesis that non-aminoacylation of mitochondrial tRNAs by bacterial synthetases is linked to the large sequence and structural relaxation of the organelle encoded tRNAs, itself a consequence of the high rate of mitochondrial genome divergence.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22402012     DOI: 10.1016/j.biochi.2012.02.030

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  8 in total

1.  Degenerate connective polypeptide 1 (CP1) domain from human mitochondrial leucyl-tRNA synthetase.

Authors:  Qing Ye; Meng Wang; Zhi-Peng Fang; Zhi-Rong Ruan; Quan-Quan Ji; Xiao-Long Zhou; En-Duo Wang
Journal:  J Biol Chem       Date:  2015-08-13       Impact factor: 5.157

2.  Thermodynamic properties distinguish human mitochondrial aspartyl-tRNA synthetase from bacterial homolog with same 3D architecture.

Authors:  Anne Neuenfeldt; Bernard Lorber; Eric Ennifar; Agnès Gaudry; Claude Sauter; Marie Sissler; Catherine Florentz
Journal:  Nucleic Acids Res       Date:  2012-12-28       Impact factor: 16.971

3.  Identity elements for the aminoacylation of metazoan mitochondrial tRNA(Arg) have been widely conserved throughout evolution and ensure the fidelity of the AGR codon reassignment.

Authors:  Gabor L Igloi; Anne-Katrin Leisinger
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

4.  Human mitochondrial leucyl tRNA synthetase can suppress non cognate pathogenic mt-tRNA mutations.

Authors:  Hue Tran Hornig-Do; Arianna Montanari; Agata Rozanska; Helen A Tuppen; Abdulraheem A Almalki; Dyg P Abg-Kamaludin; Laura Frontali; Silvia Francisci; Robert N Lightowlers; Zofia M Chrzanowska-Lightowlers
Journal:  EMBO Mol Med       Date:  2014-01-10       Impact factor: 12.137

Review 5.  tRNA biology in mitochondria.

Authors:  Thalia Salinas-Giegé; Richard Giegé; Philippe Giegé
Journal:  Int J Mol Sci       Date:  2015-02-27       Impact factor: 5.923

Review 6.  The mammalian mitochondrial epitranscriptome.

Authors:  Pedro Rebelo-Guiomar; Christopher A Powell; Lindsey Van Haute; Michal Minczuk
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2018-12-04       Impact factor: 4.490

7.  Mitochondrial Transcription Factor A (TFAM) Binds to RNA Containing 4-Way Junctions and Mitochondrial tRNA.

Authors:  Timothy A Brown; Ariana N Tkachuk; David A Clayton
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

8.  Evolutionary Adjustment of tRNA Identity Rules in Bacillariophyta for Recognition by an Aminoacyl-tRNA Synthetase Adds a Facet to the Origin of Diatoms.

Authors:  Gabor L Igloi
Journal:  J Mol Evol       Date:  2022-03-24       Impact factor: 2.395

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.